OFFICIAL PUBLICATION OF

by its subsidiary APPco

Melanoma treatment to be PBS-listed

Megan Haggan 29/06/2015

melanoma: dermatologist examines mole on woman's shoulder

MSD has welcomed the Federal Government’s announcement that patients with the most deadly form of skin cancer – advanced melanoma – will be able to access the company’s anti-PD1 immunotherapy (pembrolizumab) on the PBS. Keytruda is a prescription-only medicine suitable for adult patients with unresectable or metastatic melanoma. News that Keytruda will be listed on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Category killer’ CWH has scope for growth

Easier said than done. I agree with you, but you know how hard it is too.

D vL

‘Category killer’ CWH has scope for growth

You're under no obligation to provide advice on that product. In fact, you probably shouldn't because you have not screened…

Bart Pharm

Did wave of protest fail to break?

Are they? STILL SOLICITING BRIBES!

D vL

Did wave of protest fail to break?

Coles and Woolies have been good for competition? Have you not followed the Senate inquiry into the supermarkets and how…

Bart Pharm

Melanoma treatment to be PBS-listed

Previous Newly-identified enzyme key player in diabetes

Next MERS: thanks to international travel, Australia's not immune

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Newly-identified enzyme key player in diabetes

Next MERS: thanks to international travel, Australia's not immune

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.